Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Trichopoulos

Showing results (191-200 of 390) with videos related to

Pageof 39
Sort By:
Plos One|July 4, 2008
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3)Alpa V Patel, Iona Cheng, Federico Canzian, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2010
A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumSara Lindström, Jing Ma, David Altshuler, et al.
Breast Cancer Research : BCR|April 19, 2015
Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control studyKaja Tikk, Disorn Sookthai, Renée T Fortner, et al.
International Journal of Cancer|August 12, 2005
Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC)Tobias Pischon, Petra H Lahmann, Heiner Boeing, et al.
American Journal of Epidemiology|March 7, 2008
Smoking and lymphoma risk in the European prospective investigation into cancer and nutritionAlexandra Nieters, Sabine Rohrmann, Nikolaus Becker, et al.
Blood|June 6, 2014
Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohortFatemeh Saberi Hosnijeh, Qing Lan, Nathaniel Rothman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 7, 2009
Physical activity and ovarian cancer risk: the European Prospective Investigation into Cancer and NutritionPetra H Lahmann, Christine Friedenreich, Mandy Schulz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 21, 2013
Circulating biomarkers of tryptophan and the kynurenine pathway and lung cancer riskShu-Chun Chuang, Anouar Fanidi, Per Magne Ueland, et al.
Plos One|March 11, 2011
Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3Sara Lindstrom, Fredrick Schumacher, Afshan Siddiq, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2013
Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortiumAlison M Mondul, Irene M Shui, Kai Yu, et al.
Pageof 39

Showing results (191-200 of 390) with videos related to

Sort By:
Pageof 39
Plos One|July 4, 2008
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3)Alpa V Patel, Iona Cheng, Federico Canzian, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2010
A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumSara Lindström, Jing Ma, David Altshuler, et al.
Breast Cancer Research : BCR|April 19, 2015
Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control studyKaja Tikk, Disorn Sookthai, Renée T Fortner, et al.
International Journal of Cancer|August 12, 2005
Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC)Tobias Pischon, Petra H Lahmann, Heiner Boeing, et al.
American Journal of Epidemiology|March 7, 2008
Smoking and lymphoma risk in the European prospective investigation into cancer and nutritionAlexandra Nieters, Sabine Rohrmann, Nikolaus Becker, et al.
Blood|June 6, 2014
Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohortFatemeh Saberi Hosnijeh, Qing Lan, Nathaniel Rothman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 7, 2009
Physical activity and ovarian cancer risk: the European Prospective Investigation into Cancer and NutritionPetra H Lahmann, Christine Friedenreich, Mandy Schulz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 21, 2013
Circulating biomarkers of tryptophan and the kynurenine pathway and lung cancer riskShu-Chun Chuang, Anouar Fanidi, Per Magne Ueland, et al.
Plos One|March 11, 2011
Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3Sara Lindstrom, Fredrick Schumacher, Afshan Siddiq, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2013
Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortiumAlison M Mondul, Irene M Shui, Kai Yu, et al.
Pageof 39